Since its emergence, CRISPR technology has brought a tremendous leap forward in the biopharmaceutical industry. In collaboration with ViaCyte, CRISPR Therapeutics has developed two drug candidates, VCTX210 and VCTX211, both of which are gene-edited, allogeneic, stem cell-derived candidates for the treatment of type 1 diabetes. By transplanting pancreatic cells differentiated from stem cells, these therapies […]
Category: Diabetes news
Breakthrough in the Treatment of Diabetes Using Chemical Reprogramming Technology
In January 2025, Professor Deng Hongkui’s research team, in collaboration with Professor Guan Jingyang’s team at Peking University, published their latest research findings entitled “A Rapid Chemical Reprogramming System to Generate Human Pluripotent Stem Cells” in Nature, a renowned international academic journal.This study not only revealed the key epigenetic barriers in the chemical reprogramming system […]
Groundbreaking Gene Therapy for Type 2 Diabetes and Obesity Achieves Milestone Progress
On May 19, 2025, Fractyl Health, Inc. announced that its groundbreaking gene therapy for patients with type 2 diabetes and obesity had achieved milestone progress, offering durable efficacy and safety with a single dose, along with limited systemic exposure to glucagon-like peptide-1 (GLP-1).Known as RJVA-001, this therapeutic approach is designed to target pancreatic cells and […]
EASD Releases Positive Clinical Trial Results for Tirzepatide (Mounjaro) in Diabetes Treatment
At the annual meeting of the European Association for the Study of Diabetes (EASD) in September, clinical trial results published in The Lancet showed that tirzepatide, sold under the brand name Mounjaro, significantly improved glycemic control and weight management in children and adolescents with type 2 diabetes, most of whom had responded poorly to existing […]
Type 2 Diabetes Therapy: Oral GLP-1 Receptor Agonist Orforglipron Achieves Success in Third Phase 3 Clinical Trial
On June 21, 2025, Eli Lilly and Company, a U.S. pharmaceutical firm, announced positive key results from the first Phase 3 ACHIEVE-1 clinical trial of its investigational oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist Orforglipron. The company plans to submit a regulatory application for the treatment of type 2 diabetes in 2026.Unlike traditional injectable GLP-1 […]
New Clinical Progress Made in Stem Cell Therapy for Diabetes
Stem cell therapy has emerged as a technical approach for the treatment of diabetes, showing promising results in the laboratory and attracting extensive attention in the field. However, according to a recent report in Nature, multiple trials have for the first time demonstrated desirable clinical improvements and have entered the critical Phase II/III stage. A […]
How high is the mortality rate of diabetes?
According to public data from 2021, diabetes directly causes about 2 million deaths each year, accounting for 3% to 4% of total global deaths. Globally, this figure alone is not enough to cause panic. However, this data only counts direct causes of death. When diabetes-related complications (such as cardiovascular and cerebrovascular diseases, renal failure, infections, […]
Who are the main people affected by diabetes
Who are the main people affected by diabetes? According to publicly available statistics, most people with diabetes are adults aged 20 and over, while there is limited public data on those under 20. However, this does not mean minors are free from the risk of diabetes. There are about 9.1 million people living with type […]
Forecast: The figure will approach 853 million by 2050
Diabetes is a disease with an extremely high incidence rate, affecting patients worldwide. According to public reports, the global prevalence of diabetes reached 11.11% in 2024, with the total number of patients exceeding 589 million, among which China had the largest number of diabetes patients globally. It is projected that by 2050, the number of […]
Diabetes is highly prevalent in the United States
Diabetes is highly prevalent in the United States, with 39 million people living with the condition. Are you one of them? Such a large number of diabetes patients in the U.S. deserves our full attention. First of all, if you are a patient, there is no need to panic. With advances in science and technology, […]